Medical Director, Liver Transplant Program. Johns Hopkins University School of Medicine

Melissa Palmer, MD has been a Hepatologist for over 35 years and is an experienced biotech/pharma executive. She is currently CEO of Liver Consulting LLC, consulting exclusively to biotech and pharmaceutical companies on hepatology-related issues such as: innovative trial designs for all liver diseases including metabolic dysfunction-associated steatotic hepatitis (MASH), PBC, Hepatitis B and D, primary sclerosing cholangitis (PSC), alcohol- associated liver disease and all aspects of liver disease drug development from pre-IND to NDA.

Dr. Dina Halegoua-De Marzio is a transplant hepatologist and is currently a Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University. She completed her residency in internal medicine and fellowships in gastroenterology and transplant hepatology at Thomas Jefferson University Hospital (TJUH). She developed the first adult Fatty Liver Center in the Delaware Valley and currently serves as its director. She also serves as the Director of GI Research at TJUH and Associate Chief for the Division of Gastroenterology and Hepatology at TJUH.

Chemical Biology PhD Candidate at the University of Michigan, working under Dr. Jonathan Sexton. Focused on using patient-derived liver organoids to model clinically significant hepatotoxicity in an in-vitro model system.

Dr. Hayashi is the Associate Director of DILI within the Division of Hepatology and Nutrition, FDA. He received his Bachelor of Arts in microbiology at UCLA and MD at University of California (UC), San Diego. After completing residency and gastroenterology fellowship at UC Davis in Sacramento, California, he completed a clinical research fellowship in the Liver Diseases Section, NIDDK, NIH. He then completed a transplant fellowship at the University of Colorado, Denver. He completed a Master of Public Health at Saint Louis University (SLU), St.

Dr. Jin Ge is a transplant hepatologist and Assistant Professor of Medicine at UCSF. He serves as the Director of Clinical AI at UCSF Gastroenterology. His research focuses on using clinical informatics, data science and artificial intelligence to improve care for patients with advanced liver diseases. In particular, he has been extensively involved in the deployment and development of hepatology related use-cases of generative artificial intelligence and large language models. Dr.

Associate Professor of Medicine. Gastroenterologist and Transplant Hepatologist. Mayo Clinic Florida

Robert Wong, MD, MS, FACG, FAASLD is a Clinical Associate Professor of Medicine (Affiliated) in the Division of Gastroenterology and Hepatology, Stanford University School of Medicine, and staff physician in the Gastroenterology and Hepatology Section at Veterans Affairs Palo Alto Healthcare System. He completed gastroenterology and hepatology fellowship at Stanford University School of Medicine, where he also completed a Master's in Epidemiology and Clinical Research.

Dr. Yapali received her medical degree from Istanbul University, Cerrahpasa School of Medicine, English Curriculum. She completed her residency in Internal Medicine at Marmara University in 2008 and her Gastroenterology fellowship at Ege University, Division of Gastroenterology, in 2012. From 2012 to 2014, she pursued a Hepatology Research Fellowship at the University of Michigan, Division of Gastroenterology and Hepatology, under the mentorship of Professor Anna Lok.

I graduated from medical school in 1996. After completing my specialization in Gastroenterology in 2005, I spent three years at the Department of Gastroenterology and Hepatology at the University of Michigan, where I conducted research on antiviral resistance in hepatitis B virus (HBV) infection and liver transplantation and completed my Hepatology training. I was appointed Associate Professor in 2010 and promoted to Professor in 2017. I am currently working in the Department of Gastroenterology at Acıbadem University Faculty of Medicine.